Sundaram Preethi's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Jun 12, 2025
- Accession no.
- 0001161697-25-000189
- Filed
- Jun 12, 2025
- Trade date
- Jun 10-11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $103.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sundaram PreethiCIK 0001872422 | Officer (Chief Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Common Stock, par value $0.001 per share | SSaleDisposed | −2,324 | $26.41 | −$61,376.84 | 42,681 | Direct | |
| Jun 11, 2025 | Common Stock, par value $0.001 per share | SSaleDisposed | −1,600 | $26.42 | −$42,272 | 41,081 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.